Table 1.
Demographic and clinical data for study cohort.
| ID | Reason for referral |
Age (yr) |
Gender | CT Scan | MRI | Pancreatic elastase – 1 (units/mg) |
EUS Score (0–9) |
ePFT Peak Bicarbonate (meq/L) |
Pancreatic fluid protein conc. (mg/mL) |
Endoscopic Biopsy (gastric, duodenum) |
|---|---|---|---|---|---|---|---|---|---|---|
| CAP1 | abdominal pain | 28 | male | normal | normal | n/a | 3 | 84 | 1.2 | normal |
| CAP2 | abdominal pain | 53 | female | normal | normal | 148 (diarrhea) | 1 | 92 | 0.8 | gastropathy |
| CAP3 | abdominal pain | 54 | male | normal | normal | 202 | n/a | 114 | 0.6 | normal |
| CP1 | chronic pancreatitis | 64 | female | atrophy, calcifications, strictured and dilated duct | atrophy, dilated and strictured duct, filling effects, low T1 signal, dilated side branches | 221 | n/a | 37 | 1.1 | duodenitis, gastropathy |
| CP2 | chronic pancreatitis | 60 | female | atrophy, calcifications, strictured and dilated duct | n/a | n/a | 8 | 54 | 0.6 | normal |
| CP3 | chronic pancreatitis | 52 | female | n/a | atrophy, dilated and strictured duct, low T1 signal, dilated side branches | <15 | 5 | 38 | 0.7 | normal |
CT, indicates computed tomography; MRI, magnetic resonance imaging; EUS, endoscopic ultrasound; ePFT, endoscopic pancreas function test; CP, chronic pancreatitis; conc., concentration; n/a, not available.